Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 16NIH 7INDUSTRY 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 58Lymphoid 41Head & Neck 36Sarcoma 35Genitourinary 34Thoracic 32Gastrointestinal 30Other hematologic neoplasm 25Gynecologic 21Breast 21Classical hematology 5Myeloid 3Dermatologic 3Tumor-Agnostic 2Plasma cell 2Other solid neoplasm 1Other 1Endocrine 1

Conditions

Solitary Fibrous Tumor, Pleural 1Mesothelioma, Malignant 1

Interventions

Cisplatin 6Pemetrexed 5Carboplatin 4Standard of Care 3Specimen Handling 3Practice Guidelines as Topic 3Interviews as Topic 3Immunoenzyme Techniques 3Docetaxel 3raltitrexed 2Vincristine 2Trabectedin 2N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide 2Irinotecan 2Immunohistochemistry 2Gemcitabine 2Etoposide 2Early Intervention, Educational 2Bortezomib 2AEG 35156 2temsirolimus 1sabarubicin 1pembrolizumab 1nintedanib 1halofuginone 1ascrinvacumab 1Triptorelin Pamoate 1Thrombopoietin 1Theophylline 1SB939 compound 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Radiotherapy × Other solid neoplasm × Clear all
NCT00227630 2012-07-18

Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
59 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

Data powered by HemOnc (CC BY 4.0) Colophon âš¡